United States, Massachusetts — Boston, Massachusetts

United States, Massachusetts is a clinical research site located in Boston, Massachusetts, United States 02115.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

United States, Massachusetts has participated in 3 clinical trials.

Therapeutic areas: Includes: Hereditary Angioedema, Glioma, HCV Infection.

Sponsors: CSL Behring, Institut de Recherches Internationales Servier, Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for United States, Massachusetts?

United States, Massachusetts has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has United States, Massachusetts conducted?

United States, Massachusetts has 3 clinical trials on record. Their work covers Includes: Hereditary Angioedema, Glioma, HCV Infection.

Is United States, Massachusetts accredited by Crixeo Health?

United States, Massachusetts has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about United States, Massachusetts?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.